QT
CYTK icon

Quantamental Technologies’s Cytokinetics CYTK Stock Holding History

Quantamental Technologies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,270
Closed -$26K – 1531
2019
Q1 		$26K Buy
3,270
+870
+36% +$6.4K 0.01% 1042
2018
Q4 		$15K Buy
+2,400
New +$17.6K 0.01% 1069

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Quantamental Technologies's CYTK Position: Q2 2019 in Review

Quantamental Technologies sold out of Cytokinetics (CYTK) in Q2 2019, closing a stake of 3,270 shares — an estimated $26K sold.

Quantamental Technologies first reported a position in CYTK in Q4 2018 and held it in 2 quarters. The position peaked at $26K in Q1 2019. 134 funds tracked by Wall St. Rank hold CYTK as of Q2 2019.

  • Quantamental Technologies reported no remaining Cytokinetics position as of Q2 2019 after selling out during the quarter.
  • Quantamental Technologies sold 3,270 Cytokinetics shares in Q2 2019, an estimated $26K.
  • Quantamental Technologies first reported a position in Cytokinetics in Q4 2018 and held it in 2 quarters.
  • Quantamental Technologies's Cytokinetics position peaked at $26K in Q1 2019.
  • 134 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2019.

Based on Quantamental Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.